About ShanX Medtech
ShanX Medtech is a company based in Eindhoven (Netherlands) founded in 2019. ShanX Medtech has raised $17.53 million across 3 funding rounds from investors including European Union, Borski Fund and NextGen Ventures. ShanX Medtech offers products and services including KAIROS. ShanX Medtech operates in a competitive market with competitors including Access Bio, SD Biosensor, Lumos Diagnostics, Fluxergy and Module Innovations, among others.
- Headquarter Eindhoven, Netherlands
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$17.53 M (USD)
in 3 rounds
-
Latest Funding Round
Not available
-
Investors
European Union
& 5 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of ShanX Medtech
ShanX Medtech offers a comprehensive portfolio of products and services, including KAIROS.
Provides ultra-rapid testing for bacterial infections to guide antibiotic treatment
Funding Insights of ShanX Medtech
ShanX Medtech has successfully raised a total of $17.53M across 3 strategic funding rounds. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in ShanX Medtech
ShanX Medtech has secured backing from 6 investors, including institutional and venture fund investors. Prominent investors backing the company include European Union, Borski Fund and NextGen Ventures.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
-
|
Locked | Locked | Locked | |
|
-
|
Locked | Locked | Locked | |
|
-
|
Locked | Locked | Locked |
Investor details for ShanX Medtech
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by ShanX Medtech
Investment portfolio details for ShanX Medtech
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - ShanX Medtech
Detailed financials for ShanX Medtech
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Shanx Medtech Comparisons
Peer comparison for ShanX Medtech
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of ShanX Medtech
ShanX Medtech operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Access Bio, SD Biosensor, Lumos Diagnostics, Fluxergy and Module Innovations, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
In vitro rapid diagnostic tests, biosensor, and molecular diagnostic products for diagnosis of infectious diseases.
|
|
| Locked | Locked | Locked |
Biosensors for point-of-care diagnostics are developed by SD Biosensor.
|
|
| Locked | Locked | Locked |
Diversified diagnostic assays and readers are developed for point-of-care use.
|
|
| Locked | Locked | Locked |
Provides diagnostic devices and software for clinical and veterinary point-of-care testing.
|
|
| Locked | Locked | Locked |
Diagnostics strip for bacterial detection
|
|
| Locked | Locked | Locked |
Point-of-care diagnostic products for diabetes and tuberculosis are provided.
|
Detailed competitors of ShanX Medtech
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Shanx Medtech
Complete news archive for ShanX Medtech
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about ShanX Medtech
ShanX Medtech was founded in 2019 and raised its 1st funding round 4 years after it was founded.
ShanX Medtech is headquartered in Eindhoven, Netherlands. It is registered at Eindhoven, Noord-brabant, Netherlands.
Sophia E Shanko is the current CEO of ShanX Medtech.
ShanX Medtech is a funded company, having raised a total of $17.53M across 3 funding rounds to date.
Provider of in vitro diagnostic platforms for antibiotic testing. It offers diagnostic solutions to support doctors in making informed treatment decisions for bacterial infections. The flagship product, KAIROS, is a direct from sample device that provides rapid results, enabling healthcare professionals to administer correct antibiotics promptly. It aims to enhance patient outcomes and eliminate the spread of antibiotic resistant bacteria by streamlining the diagnostic process.
ShanX Medtech's top competitors include Access Bio, SD Biosensor and Lumos Diagnostics.
ShanX Medtech offers KAIROS.
ShanX Medtech has 6 investors. Key investors include European Union, Borski Fund, NextGen Ventures, CbusineZ, and BOM.